Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ("DEB"), a rare genetic pediatric connective tissue disorder.

Biotechnology

Aegle Therapeutics

Aegle Therapeutics' headquarters in Woburn, MA, United States

Shelley A. Hartman

Heidi Kempinski

Evangelos V. Badiavas

Lonnie Moulder

Robert Williamson

David Schimel

Robert Ryan

Mike Tanji

Aegle Therapeutics' Leadership Team includes Evangelos V. Badiavas and 4 others.

About

People (4)

Evangelos V. Badiavas

Heidi Kempinski

Shelley A. Hartman

Willistine Lenon

Jobs